Volume 25 Issue 1-5
Volume 25 Issue 5
Genome Sequencing in Medicine
Oct-Nov 2012
Will Insurance Cover Genome Sequencing?
By CRG staff - interview with Joanne Armstrong
Doctors (Cautiously) Onboard
By Jeremy Lazarus
Privacy in the Age of Revelation
By CRG staff - interview with Anita Allen
In Memoriam: A Tribute to Barry Commoner
By Sheldon Krimsky
More Science Than Art
By Paul Billings
The Genome Sequencing and Privacy Report: A Missed Opportunity
By Mark A. Rothstein
Computer Science
By CRG staff - interview with Steven Salzberg
Managing Your Genetic Portfolio
By Maggie Curnutte, Melody Slashinski
Great Expectations, Modest Returns
By Donna Dickenson
Questioning the Utility of Whole Genome Sequencing
By Helen Wallace
The Complicated Cost-Benefit Calculus of Newborn Screening
By Vani Kilakkathi
Notes From the Field: Forensic Genetics in India
By Jeremy Gruber
Topic Update: GMO Labeling
By CRG Staff
Editor's Note
By Samuel W. Anderson
Volume 25 Issue 4
Returning Results
Jul-Aug 2012
What the Doctor Orders
By CRG staff - interview with Robert Green
Returning the Favor
By CRG staff - interview with Laura Rodriguez
A Problematic Reading of the Genetic History of the Jews
By Paul S. Appelbaum, Diana Muir Appelbaum
Genomic Incidental Findings: Metaphors and Methods
By James Evans, Jonathan S. Berg
Toward Inclusive Genomics
By Joon-Ho Yu, Wylie Burke
Déjà Vu All Over Again?
By Marc Williams
Children First
By Bartha Knoppers
Who Has the Right to Know?
By Elana Brief, Judy Illes
Sharing and Caring
By CRG staff - interview with Francine Gachupin
Returning Research Results: Unresolved Issues
By Karen Maschke
U.S. Appeals Court Reaffirms Ruling in Favor of Myriad’s Gene Patents
By CRG Staff
Editor's Note
By Samuel W. Anderson
Volume 25 Issue 3
Genetics and Animal Biodiversity
Apr-May 2012
Trivializing Extinction
By Rob DeSalle
Smugglers, Poachers, and DNA Barcoding
By CRG staff - interview with Mark Stoeckle
The Frozen Zoo
By Oliver Ryder
The Genetic Jungle
By Guy Reeves
Hatch and Release
By Camilo Rodríguez-Beltrán
GM Mosquitoes: Flying Through the Regulatory Gaps?
By Lim Li Ching
A Primer on GMOs and International Law
By Phil Bereano
Supreme Court Orders New Review of Myriad Gene Patents
By CRG Staff
Topic Update: Database Expansion in New York
By CRG Staff
Topic Update: Protections for the Innocent in Massachusetts
By CRG Staff
Topic Update: Rhino DNA Database Leads to Poacher Arrests
By CRG Staff
Editor's Note
By Samuel W. Anderson
Volume 25 Issue 1
Genetics in 20 Years
Jan-Feb 2012
We Are the Ninety-Nine Percent
By James Evans
Interview: Eric Green
By CRG staff - interview with Dr. Eric Green, Director of the National Human Genome Research Institute
Designer Eggs and Stem Cell Sausage
By Henry T. Greely
At the Minnesota State Fair (in 2032)
By George J. Annas
The Future of Consumer Genomics: Sharing Is Caring
By CRG staff - interview with Anne Wojcicki, co-founder and CEO of 23andMe
Unrequited Love: Reflections on Genomics, as Written in 2032
By Arthur L. Caplan
The $10 Genome
By Paul Billings
Deflated Expectations
By Emily Senay
The Future of Genetic Nondiscrimination Legislation
By CRG staff - interview with Congresswoman Louise Slaughter
Safe Bets: Priorities for Genetic Research
By CRG staff - interview with Pfizer's Joe Hammang
Breaking the Bonds of Race and Genomics
By Dorothy Roberts
Expect Changes: Genetics in 20 Years
By George Church
Some Assembly Required
By CRG staff - interview with Steven Salzberg
Toxicology in the Genome
By Sheldon Krimsky
The Genomic Imaginary
By Patricia Williams
The Tree of Life
By Rob DeSalle
Meiogenics: Synthetic Biology Meets Transhumanism
By Stuart Newman
Labeling Genetically Engineered Foods in California
By Pamm Larry
Developmental Science and the Role of Genes in Development
By Richard M. Lerner
In Memoriam: Charlie Weiner
By Sheldon Krimsky
Editor's Note
By Samuel W. Anderson
Search: GeneWatch
Created in 1999 by the Council for Responsible Genetics, the Safe Seed Pledge helps to connect non-GM seed sellers,distributors and traders to the growing market of concerned gardeners and agricultural consumers. The Pledge allows businesses and individuals to declare that they "do not knowingly buy, sell or trade genetically engineered seeds," thus assuring consumers of their commitment.
View Project
Rapid developments in biotechnology over the last two decades have enabled corporations and scientists to alter nature's handiwork for commercial profit. The patent, a tool originally created to insure that inventors could share in the financial returns and benefits deriving from the use of their nventions, has become the primary mechanism through which the private sector advances its claims to ownership over genes, proteins, and entire organisms.
View Project